ANDA 71357, held by Sun Pharm Industries. Tolazamide.
As of Nov 16, 2026, ANDA 71357 (Tolazamide), held by Sun Pharm Industries, was first approved by FDA on Jul 16, 1987, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 16, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tolazamide100MG ยท tablet;oral | Tolazamide | Discontinued |
| Sep 28, 2006 | Supplement 18Labeling | Approved | None posted |
| May 16, 2000 | Supplement 9Manufacturing | Approved | None posted |
| May 16, 2000 | Supplement 8Manufacturing | Approved | None posted |
| Dec 5, 1997 | Supplement 7Manufacturing | Approved | None posted |
| Feb 24, 1997 | Supplement 6Manufacturing | Approved | None posted |
| Jun 22, 1995 | Supplement 4Manufacturing | Approved | None posted |
| Jan 3, 1994 | Supplement 3Manufacturing | Approved | None posted |
| Aug 8, 1991 | Supplement 2Labeling | Approved | None posted |
| Jun 18, 1991 | Supplement 1Labeling | Approved | None posted |
| Jul 16, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters